FamilieSCN2A and Cellectricon Partner to Accelerate Drug Development for a Top Autism and Epilepsy Gene, SCN2A
The FamilieSCN2A Foundation, the leading nonprofit organization in the world dedicated to improving the lives of individuals affected by SCN2A-related disorders (SRDs), is proud to announce a strategic partnership with Cellectricon, a cutting-edge biotechnology company specializing in advanced neuronal assay technologies.